Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria. The Germany-based company, which developed the...
A South African firm will begin producing the Pfizer-BioNTech coronavirus vaccine, the first time that the shot will be produced in Africa, Pfizer announced Wednesday. The...
U.S. regulators have approved a new pneumonia vaccine from Merck, more than a month after OK’ing an improved version of rival Pfizer’s shot. Both new shots...
Mental health practitioners in Singapore will be able to utilize artificial intelligence (AI) to diagnose senior citizens with illnesses such as anxiety, stress, and depression all...
The Mental Health Tech Landscape Review, released gby Future Care Capital (FCC), not only recommends a range of measures to enable higher quality care through the...
In a medical first, researchers harnessed the brain waves of a paralyzed man unable to speak — and turned what he intended to say into sentences...
Moderna has begun human trials for an mRNA vaccine called mRNA-1010, that targets multiple influenza strains, the company announced Wednesday. The American pharmaceutical and biotechnology firm based in Cambridge, aims on the long run for one seasonal shot for...
